Document is current
Any future updates will be listed below
-
Authors
Yeh, Christine Yiwen https://orcid.org/0000-0003-4217-8555
Aguirre, Karmen
Laveroni, Olivia https://orcid.org/0009-0008-4416-0475
Kim, Subin https://orcid.org/0000-0001-9339-5758
Wang, Aihui https://orcid.org/0000-0002-4497-7441
Liang, Brooke https://orcid.org/0000-0002-8823-2804
Zhang, Xiaoming
Han, Lucy M.
Valbuena, Raeline https://orcid.org/0000-0001-7877-4151
Bassik, Michael C. https://orcid.org/0000-0001-5185-8427
Kim, Young-Min
Plevritis, Sylvia K. https://orcid.org/0000-0003-2796-9180
Snyder, Michael P. https://orcid.org/0000-0003-0784-7987
Howitt, Brooke E. https://orcid.org/0000-0002-0309-6680
Jerby, Livnat https://orcid.org/0000-0002-4037-386X
- License Information
-
More Information
Article History
Received: 4 October 2023
Accepted: 25 July 2024
First Online: 23 August 2024
Competing interests
: M.P.S. is a cofounder and scientific advisor of Personalis, SensOmics, Qbio, January AI, Fodsel, Filtricine, Protos, RTHM, Iollo, Marble Therapeutics and Mirvie. M.P.S. is a scientific advisor of Yuvan, Jupiter, Neuvivo, Swaza and Mitrix. M.C.B has outside interest in DEM Biopharma. The other authors declare no competing interests.
